ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2147

Risks to Visit Emergency Room in Patients with Rheumatoid Arthritis: A Two-Year Retrospective Study

Yoshiki Nagai, Naoto Yokogawa, Kota Shimada and Shoji Sugii, Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects III: Infections/Risk Factors for Incident Rheumatoid Arthritis/Metrology/Classification/Biomarkers/Predictors of Rheumatolid Arthritis Activity & Severity

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Patients with rheumatoid arthritis (RA) suffer from both physical disabilities and medical comorbidities and tend to use emergency room for many reasons. However, the detail has not been well investigated from the perspective of emergency medicine. The aim of this study is to identify the risks to visit emergency room in RA patients.

Methods:

We retrospectively reviewed all emergency room visits in RA patients followed at Tokyo Metropolitan Tama Medical Center from April 2007 to March 2009 using an electric health record system. We compared the characteristics of RA patients who visited emergency room (“ER user group”) to those who did not visit emergency room (“Control”). We compared the background characteristics between the two groups. A logistic regression analysis was performed to evaluate the risks of emergency room visits.

Results:

“ER user group” and “Control” included 294 and 298 patients. The background characteristics of both groups were summarized in Table 1. By a logistic regression analysis, cardiovascular diseases, prednisolone>5mg/d, anti-TNF agents, age over 65, and pulmonary diseases predicted emergency room visits with odds ratio of 4.2, 3.5, 3.3, 1.7, and 1.6 respectively (Table2).

Conclusion:

Preexisting cardiovascular disease, prednisolone>5mg/d, and anti-TNF agents were considered higher risks for emergency room visits in patients with RA.

Table 1

Background characteristics of “ER user” and “Control”

ER user (294 pts)

N (%)

Control (298 pts)

N (%)

p

Age, year±SD

68.0±11.1

63.1±12.3

<0.001

Disease duration, year±SD

15.3±12.6

12.8±11.7

 0.017

Female

235 (80%)

241 (81%)

NS

Diabetes mellitus

49 (17%)

27 (9%)

 0.005

Pulmonary diseases*1

82 (28%)

49 (16%)

 0.001

Cardiovascular diseases*2

40 (14%)

8 (3%)

<0.001

Glucocorticoids

214 (73%)

149(50%)

<0.001

Prednisolone equivalent (mg/day)

4.2±4.0

2.2±2.6

<0.001

Methotrexate

146 (50%)

143 (48%)

NS

Anti-TNF agents

28 (10%)

12 (4%)

0.007

Salazosulfapyridine

54 (18%)

55 (18%)

NS

Bucillamine

43 (15%)

32 (11%)

NS

*1 Pulmonar diseases: interstitial lung disease, old tuberculosis, asthma, bronchiectasis, nontuberculous mycobacteriosis, chronic obstructive pulmonary disease

*2 Cardiovascular diseases: heart failure, old myocardial infarction, angina pectoris

NS: not statistically significant


Table 2

Multivariate logistic analysis to predict emergency room visits

Variable

Odds ratio

P

Cardiovascular disease

4.2

<0.001

Prednisolone equivalent >5mg/d

3.5

<0.001

Anti-TNF agents

3.3

0.001

Age over 65

1.7

0.003

Diabetes mellitus

1.7

NS (0.051)

Pulmonary disease

1.6

0.030

*1 Pulmonar diseases: interstitial lung disease, old tuberculosis, asthma, bronchiectasis, nontuberculous mycobacteriosis, chronic obstructive pulmonary disease

*2 Cardiovascular diseases: heart failure, old myocardial infarction, angina pectoris

NS: not statistically significant


Disclosure:

Y. Nagai,
None;

N. Yokogawa,
None;

K. Shimada,
None;

S. Sugii,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risks-to-visit-emergency-room-in-patients-with-rheumatoid-arthritis-a-two-year-retrospective-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology